Blood flow quantification with permeable contrast agents: a valid technique?
van den Hoff
Jörg
J
D000818:Animals; D001011:Aorta / Q000503:physiopathology; D001810:Blood Volume / Q000502:physiology; D002199:Capillary Permeability / Q000502:physiology; D002277:Carcinoma / Q000098:blood supply* / Q000378:metabolism; D045744:Cell Line, Tumor; D002933:Cineradiography; D004195:Disease Models, Animal; D019788:Fluorodeoxyglucose F18; D005947:Glucose / Q000378:metabolism*; D006499:Hepatic Artery / Q000503:physiopathology; D007091:Image Processing, Computer-Assisted; D008099:Liver / Q000098:blood supply / Q000378:metabolism; D008113:Liver Neoplasms / Q000098:blood supply* / Q000378:metabolism; D008297:Male; D011169:Portal Vein / Q000503:physiopathology; D049268:Positron-Emission Tomography / Q000295:instrumentation; D011817:Rabbits; D019275:Radiopharmaceuticals; D012039:Regional Blood Flow / Q000502:physiology; D015898:Tomography Scanners, X-Ray Computed; D014057:Tomography, X-Ray Computed
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D005947:Glucose